Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons
about
HIV-associated neurocognitive disorder--pathogenesis and prospects for treatmentInteractions of Opioids and HIV Infection in the Pathogenesis of Chronic PainInteraction of paroxetine with mitochondrial proteins mediates neuroprotection.Morphine enhances HIV-1SF162-mediated neuron death and delays recovery of injured neuritesEffects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergismHIV-1 transgenic female rat: synaptodendritic alterations of medium spiny neurons in the nucleus accumbens.Neonatal intrahippocampal HIV-1 protein Tat(1-86) injection: neurobehavioral alterations in the absence of increased inflammatory cytokine activation.Anxiety-like behavior of mice produced by conditional central expression of the HIV-1 regulatory protein, Tat.Neuronal ferritin heavy chain and drug abuse affect HIV-associated cognitive dysfunction.HIV-1 alters neural and glial progenitor cell dynamics in the central nervous system: coordinated response to opiates during maturation.Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens.Interactive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na⁺ influx, mitochondrial instability, and Ca²⁺ overload.Transient hypercapnia reveals an underlying cerebrovascular pathology in a murine model for HIV-1 associated neuroinflammation: role of NO-cGMP signaling and normalization by inhibition of cyclic nucleotide phosphodiesterase-5HIV transactivator of transcription enhances methamphetamine-induced Parkinson's-like behavior in the rats.Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.HIV-1 Tat activates a RhoA signaling pathway to reduce NMDA-evoked calcium responses in hippocampal neurons via an actin-dependent mechanismEffects of chronic HIV-1 Tat exposure in the CNS: heightened vulnerability of males versus females to changes in cell numbers, synaptic integrity, and behaviorDrugs of Abuse in HIV infection and neurotoxicity.Creatine protects against mitochondrial dysfunction associated with HIV-1 Tat-induced neuronal injury.Sensitization of enteric neurons to morphine by HIV-1 Tat protein.Eradication of human immunodeficiency virus from brain reservoirs.Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia.HIV-1 proteins, Tat and gp120, target the developing dopamine systemOpiate addiction therapies and HIV-1 Tat: interactive effects on glial [Ca²⁺]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity.MicroRNAs in opioid pharmacology.Morphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain.Modeling HIV-associated neurocognitive disorders in mice: new approaches in the changing face of HIV neuropathogenesisMorphine efficacy is altered in conditional HIV-1 Tat transgenic mice.Subtype selective NMDA receptor antagonists induce recovery of synapses lost following exposure to HIV-1 Tat.Opiate drug use and the pathophysiology of neuroAIDS.Chronic HIV-1 Tat and HIV reduce Rbfox3/NeuN: evidence for sex-related effectsMorphine and microRNA Activity: Is There a Relation with Addiction?HIV-1-Tat Protein Inhibits SC35-mediated Tau Exon 10 Inclusion through Up-regulation of DYRK1A Kinase.Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic Mice.Regulation and Functional Implications of Opioid Receptor Splicing in Opioid Pharmacology and HIV PathogenesisMechanism(s) involved in opioid drug abuse modulation of HANDSynaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 Tat transgenic mice.Expression of HIV-Tat protein is associated with learning and memory deficits in the mouse.Morphine exposure during HIV encephalitis in SCID mice.Conditional Tat protein expression in the GT-tg bigenic mouse brain induces gray matter density reductions.
P2860
Q26766448-DD985914-D03D-4776-A8C1-656138A78BD7Q26768068-B642EA1A-963F-4F3F-98D4-46C71F5DE6EBQ27339182-A2F4E75C-1CB0-4DB0-AED2-A1D816EB4B3EQ28539889-D6EAC259-0165-4DD1-AD3B-F6E42103C4B2Q28660034-B9F3465A-A5D6-4CCC-896E-2D09B043166DQ30397434-BB7142F8-797D-43FE-94D1-B9312FD395B6Q30399828-11CDECAE-73F7-4339-BB58-CB075A8A0E8DQ30410538-24F6E97E-A5D0-48F2-BFE3-B0B6FFECA6AAQ30569766-9C18A4DD-72F4-4262-924C-B9B9A6A13529Q33647438-5D656C4B-4FBA-498B-A1F2-69EA7D3CFE6EQ33700996-71125225-B947-4833-B93D-86568DB05F46Q34197724-F9A3ED03-D15C-49AB-9C72-083E398E1EB2Q34483568-1C988894-C5FC-410A-BB11-415B4DD91A33Q34536059-C165EA7C-CF2D-4D28-BD44-62D6D39D9D90Q35007339-276B9413-8A20-4600-818F-97D443180964Q35007551-E8E41C78-7BC3-4E44-96EA-D5D70B349BC1Q35123216-2B5252D1-DBCF-4EBD-AA19-EE099647EDCDQ35212027-57342200-EC3F-4850-A3BB-37CA58E9D4ACQ35215063-97A3C707-BADF-4DAC-B71D-6753C5507121Q35236345-D9692841-303B-45DE-BA92-6E137B8CA1BFQ35567289-9C35BE42-875D-436B-86CE-74FBDC6C9D19Q35606725-5262A8C3-3B48-40BF-91FE-7913774ABA16Q35743630-5316C013-8F14-428C-A80A-2C334BFD8F38Q35763921-9FAC9A33-D2ED-4AFB-9C1F-8775D5424CBBQ35809571-E9331BC8-C9F0-497D-9966-CE4D52A44022Q35857045-CC49B456-6661-4B77-975F-A0E42B9BD789Q35921136-D7A50323-BFC7-4616-867E-E388B67DA3A6Q36109980-63FBB674-E45E-440F-85DE-1F76CC62577BQ36158952-01CF8FB2-A539-4DD3-BCEA-DA1B6FB5DF17Q36201412-75C271BF-90BC-448B-A08E-E7522934BFC7Q36335361-C61A320F-00BB-47F0-A09C-E89C58EAFEFAQ36386234-E7ECD5C2-AA32-4B48-B639-DDCA96F6AD5AQ36407266-6D811709-7EAC-41B6-93DC-9DF8DF2347FDQ36432328-AD985B3D-47F0-4EB1-AFBC-F84299D34166Q36505623-855E5813-8108-4836-95C4-4487990E341FQ36590733-2107B335-04D4-47D4-BBA2-EC5E2D41177EQ36605014-F3D632AA-6A9E-4E54-B83B-FFBF90F739ABQ36632791-F6D0EEC8-C58A-4FC4-984B-CE775B54F6C6Q36687603-C82F63C4-3932-44A0-8134-315385503CEAQ36728173-4376995C-B047-4356-9EFB-236BCC540808
P2860
Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Interactive comorbidity betwee ...... pathology in striatal neurons
@ast
Interactive comorbidity betwee ...... pathology in striatal neurons
@en
Interactive comorbidity betwee ...... pathology in striatal neurons
@nl
type
label
Interactive comorbidity betwee ...... pathology in striatal neurons
@ast
Interactive comorbidity betwee ...... pathology in striatal neurons
@en
Interactive comorbidity betwee ...... pathology in striatal neurons
@nl
prefLabel
Interactive comorbidity betwee ...... pathology in striatal neurons
@ast
Interactive comorbidity betwee ...... pathology in striatal neurons
@en
Interactive comorbidity betwee ...... pathology in striatal neurons
@nl
P2093
P2860
P921
P1476
Interactive comorbidity betwee ...... pathology in striatal neurons
@en
P2093
Avindra Nath
Cecilia Bull
Kurt F Hauser
Nazira El-Hage
Pamela E Knapp
Ruqiang Xu
Shreya K Buch
P2860
P304
P356
10.2353/AJPATH.2010.090945
P407
P577
2010-07-22T00:00:00Z